US2015335010A1PendingUtilityA1
Maintenance medium for primate pluripotent stem cells
Est. expiryMay 21, 2034(~7.8 yrs left)· nominal 20-yr term from priority
A01N 1/125A01N 1/126C12N 5/0696C12N 2500/34C12N 2501/00A01N 1/0226
54
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Provided are a maintenance medium for primate pluripotent stem cells, and a method for preserving and a method for controlling proliferation of primate pluripotent stem cells using the medium. The maintenance medium for human pluripotent stem cells according to the present invention includes xylose as a saccharide.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A maintenance medium for pluripotent stem cells, comprising xylose as a saccharide, which is substantially free of glucose.
2 . The maintenance medium for pluripotent stem cells according to claim 1 , wherein the primate pluripotent stem cells are human pluripotent stem cells.
3 . The maintenance medium for pluripotent stem cells according to claim 1 , wherein the primate pluripotent stem cells are human iPS cells.
4 . The maintenance medium for pluripotent stem cells according to claim 1 , wherein the xylose concentration is 0.7 to 12.0 g/L at the final concentration.
5 . The maintenance medium for pluripotent stem cells according to claim 1 , wherein the maintenance medium is a culture medium for human iPS cells containing xylose in place of glucose.
6 . The maintenance medium for pluripotent stem cells according to claim 5 , wherein the basal medium of a culture medium for human iPS cells is a DMEM/F12 medium.
7 . A method for preserving primate pluripotent stem cells, which comprises maintaining primate pluripotent stem cells using a medium comprising xylose as a saccharide, which is substantially free of glucose.
8 . The method according to claim 7 , wherein the primate pluripotent stem cells are human pluripotent stem cells.
9 . The method according to claim 7 , wherein the primate pluripotent stem cells are human iPS cells.
10 . The method according to claim 7 , wherein the xylose concentration is 0.7 to 12.0 g/L at the final concentration.
11 . The method according to claim 7 , wherein the maintenance medium is a culture medium for human iPS cells containing xylose in place of glucose.
12 . The method according to claim 11 , wherein the basal medium of a culture medium for human iPS cells is a DMEM/F12 medium.
13 . A method for controlling proliferation of primate pluripotent stem cells, which comprises inhibiting the proliferation of primate pluripotent stem cells using a medium comprising xylose as a saccharide, which is substantially free of glucose.
14 . The method according to claim 13 , which further comprises promoting the proliferation of primate pluripotent stem cells using a medium comprising glucose.
15 . The method according to claim 13 , wherein the primate pluripotent stem cells are human pluripotent stem cells.
16 . The method according to claim 13 , wherein the primate pluripotent stem cells are human iPS cells.
17 . The method according to claim 13 , wherein the xylose concentration is 0.7 to 12.0 g/L at the final concentration.
18 . The method according to claim 13 , wherein the maintenance medium is a culture medium for human iPS cells containing xylose in place of glucose.
19 . The method according to claim 18 , wherein the basal medium of a culture medium for human iPS cells is a DMEM/F12 medium.Join the waitlist — get patent alerts
Track US2015335010A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.